ORM1 and colorectal carcinoma: In addition, the finding indicating that the serum ORM1 levels of patients with CRLM were higher, as opposed to the absence of a clear difference between patients with CRC and normal subjects, suggested that ORM1 shows potential as a biomarker of CRLM.